Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
Researchers at NYU Langone Medical Center, looking into the controversial association between testosterone replacement therapy (TRT) and prostate cancer risk, found that TRT ... Read more
Researchers at the Roswell Park Cancer Institute (RPCI) recently demonstrated that mitochondrial dysfunction may help explain the greater incidence of prostate ... Read more
Researchers at the Virginia Commonwealth University School of Medicine found that Polo-like kinase 1 (PLK1) gene overexpression promotes oncogenic transformation and the migration ... Read more
Exiqon Life Sciences announced the publication of a study detailing the validation of its prognostic microRNA biomarker profile, an non-invasive way ... Read more
Exosome Diagnostics revealed positive clinical results evaluating its urine-based prostate cancer liquid biopsy test called ExoDx Prostate (IntelliScore). The study, “A Novel Urine Exosome ... Read more
Researchers analyzing clinical and pathological outcomes in men with low- and intermediate-risk prostate cancer under “active surveillance” found that — despite ... Read more
UT Southwestern Medical Center researchers have shown that medical androgen deprivation therapy, commonly used in combination with promising immunotherapies, can actually suppress the ... Read more
A retrospective study, using a national database, analyzed data from patients with prostate cancer and found that a complex surgical procedure — salvage radical prostatectomy ... Read more
